11:31 AM EST - Pharmala Biotech Holdings Inc : Announced they have been selected as the MDMA manufacturing partner for Mind Medicine Australia. Mind Medicine Australia's order will be available for delivery later this year, for use in an ethics approved healthy persons trial and will be subject to all necessary government approvals being obtained. Pharmala Biotech Holdings Inc
shares C.MDMA are trading unchanged at $0.04.
